- Trials with a EudraCT protocol (18)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
18 result(s) found for: Idiopathic Generalized Epilepsy.
Displaying page 1 of 1.
EudraCT Number: 2011-003100-21 | Sponsor Protocol Number: SP0982 | Start Date*: 2015-10-02 | |||||||||||
Sponsor Name:UCB BIOSCIENCES, Inc. | |||||||||||||
Full Title: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LACOSAMIDE AS ADJUNCTIVE THERAPY FOR UNCONTROLLED PRIMARY GENERALIZED TONIC-... | |||||||||||||
Medical condition: Epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) SK (Completed) HU (Completed) DE (Completed) ES (Completed) CZ (Completed) BE (Completed) IT (Completed) PL (Completed) FR (Completed) BG (Completed) RO (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002313-22 | Sponsor Protocol Number: ADV6770-A11CS | Start Date*: Information not available in EudraCT | ||||||||||||||||
Sponsor Name:ADVICENNE PHARMA SA | ||||||||||||||||||
Full Title: A randomised, active controlled, open-label, 2-way cross-over, multicentre study to investigate the palatability, acceptability, pharmacokinetics, safety and tolerability, and treatment compliance ... | ||||||||||||||||||
Medical condition: Children with chilhood absence epilepsy. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004379-22 | Sponsor Protocol Number: SP0961 | Start Date*: 2015-03-10 | |||||||||||
Sponsor Name:UCB BIOSCIENCES, Inc. | |||||||||||||
Full Title: An Open-Label Pilot Study to Assess the Safety of Oral Lacosamide as Adjunctive Therapy for Uncontrolled Primary Generalized Tonic-Clonic Seizures in Subjects With Idiopathic Generalized Epilepsy | |||||||||||||
Medical condition: Epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001514-29 | Sponsor Protocol Number: LAM115377 | Start Date*: 2017-08-11 | |||||||||||
Sponsor Name:GlaxoSmithKline KK | |||||||||||||
Full Title: A multi-center, uncontrolled, open-label, evaluation of Lamotrigine monotherapy on newly diagnosed typical absence seizures in children and adolescents | |||||||||||||
Medical condition: Typical absence seizure | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004375-23 | Sponsor Protocol Number: SP0962 | Start Date*: 2015-03-23 | |||||||||||
Sponsor Name:UCB BIOSCIENCES, Inc. | |||||||||||||
Full Title: An open-label extension study to assess the safety and seizure frequency associated with long-term oral lacosamide for uncontrolled primary generalized tonic-clonic seizures in subjects with idi... | |||||||||||||
Medical condition: Epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-006003-15 | Sponsor Protocol Number: E2007-M065-505 | Start Date*: 2021-12-27 | |||||||||||
Sponsor Name:Eisai Korea Inc. | |||||||||||||
Full Title: Post-Marketing Surveillance of Fycompa in Korean Patients | |||||||||||||
Medical condition: Partial-onset seizure and primary generalized tonic-clonic seizure | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000265-12 | Sponsor Protocol Number: E2007-G000-332 | Start Date*: 2011-08-31 | |||||||||||
Sponsor Name:Eisai Limited | |||||||||||||
Full Title: A Double-blind, Randomized, Placebo-controlled, Multicenter, Parallel-group Study with an Open-label Extension Phase to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generali... | |||||||||||||
Medical condition: Primary Generalized Tonic-Clonic Seizures | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) DE (Completed) LV (Completed) GR (Completed) AT (Completed) CZ (Completed) NL (Completed) PL (Completed) LT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005177-23 | Sponsor Protocol Number: N01395 | Start Date*: 2012-09-27 | |||||||||||
Sponsor Name:UCB Pharma SA | |||||||||||||
Full Title: An Open-Label, Multicenter, Single-Arm Study to Evaluate the Reduction in Nonpsychotic Behavioral Side Effects in Subjects with Epilepsy Switching from Levetiracetam to Brivaracetam due to Nonpsych... | |||||||||||||
Medical condition: Nonpyschotic Behavioural Side Effects in Subjects With Epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-004254-93 | Sponsor Protocol Number: 26489112NAP2001 INT-1 | Start Date*: 2007-11-20 | |||||||||||
Sponsor Name:Janssen-Cilag International N.V | |||||||||||||
Full Title: A Non-Randomized, Within Subject Placebo-Controlled Exploratory Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal EEG Response in Subjects with Photosensitive Epilepsy | |||||||||||||
Medical condition: Epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002769-33 | Sponsor Protocol Number: EP0132 | Start Date*: 2021-05-28 |
Sponsor Name:UCB Biopharma SRL | ||
Full Title: A Multicenter, Open-Label, Single-Arm Study to Evaluate Long-Term Safety, Tolerability, and Efficacy of Brivaracetam in Study Participants 2 to 26 Years of Age With Childhood Absence Epilepsy or Ju... | ||
Medical condition: Childhood absence epilepsy (CAE) Juvenile absence epilepsy (JAE) | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: HU (Prematurely Ended) BE (Ongoing) IT (Ongoing) PL (Completed) SK (Ongoing) Outside EU/EEA | ||
Trial results: (No results available) |
EudraCT Number: 2020-002750-24 | Sponsor Protocol Number: N01269 | Start Date*: 2021-04-16 |
Sponsor Name:UCB Biopharma SRL | ||
Full Title: A Randomized, Dose-Finding and Confirmatory, Double-Blind, Placebo-Controlled, Parallel-Group Multicenter Study With a 2-Stage Adaptive Design and Randomized Withdrawal to Evaluate the Efficacy, Sa... | ||
Medical condition: Childhood absence epilepsy and juvenile absence epilepsy | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: PL (Completed) BE (Ongoing) IT (Ongoing) SK (Ongoing) Outside EU/EEA | ||
Trial results: (No results available) |
EudraCT Number: 2011-001318-32 | Sponsor Protocol Number: P261-401 | Start Date*: 2011-11-17 | |||||||||||
Sponsor Name:Upsher-Smith Laboratories, Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intranasal Midazolam (USL261) in the Outpatient Treatment of Subjects with Seizure Clusters ARTEMIS-1: Acute Rescu... | |||||||||||||
Medical condition: epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) DE (Prematurely Ended) IT (Prematurely Ended) HU (Prematurely Ended) PL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-003556-10 | Sponsor Protocol Number: E2090-E044-317 | Start Date*: 2008-07-09 | |||||||||||
Sponsor Name:Eisai Limited | |||||||||||||
Full Title: A double-blind, randomised, placebo-controlled, multi-centre study to assess the efficacy and safety of adjunctive zonisamide in myoclonic seizures associated with idiopathic generalised epilepsy. | |||||||||||||
Medical condition: myoclonic seizures in idiopathic generalised epilepsy (IGE). | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) HU (Prematurely Ended) LT (Prematurely Ended) CZ (Completed) EE (Prematurely Ended) PL (Completed) ES (Completed) FI (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-003557-91 | Sponsor Protocol Number: E2090-E044-315 | Start Date*: 2008-07-09 | |||||||||||
Sponsor Name:Eisai Limited | |||||||||||||
Full Title: A double-blind, randomised, placebo-controlled, multicentre study to assess the efficacy and safety of adjunctive zonisamide in primary generalised tonic clonic seizures | |||||||||||||
Medical condition: Primary generalised tonic-clonic seizures (PGTCS) in idiopathic generalised epilepsy (IGE) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) HU (Prematurely Ended) LT (Prematurely Ended) FI (Prematurely Ended) CZ (Prematurely Ended) EE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001337-41 | Sponsor Protocol Number: YKP3089C025 | Start Date*: 2018-12-17 | |||||||||||
Sponsor Name:SK Life Science, Inc. | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generalized Tonic-Clonic Seizures | |||||||||||||
Medical condition: Primary Generalized Tonic-Clonic Seizures | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Ongoing) BG (Completed) CZ (Ongoing) SK (Ongoing) PL (Ongoing) DE (Ongoing) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-006696-36 | Sponsor Protocol Number: E2090-E044-318 | Start Date*: 2008-09-05 | |||||||||||
Sponsor Name:Eisai Limited | |||||||||||||
Full Title: Open label Extension Study Following Double-blind, Randomized, Placebo-controlled, Multicentre Study to Assess Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures associated with Idi... | |||||||||||||
Medical condition: myoclonic seizures in idiopathic generalised epilepsy (IGE). | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001770-29 | Sponsor Protocol Number: EP0012 | Start Date*: 2015-07-06 |
Sponsor Name:UCB BIOSCIENCES, Inc. | ||
Full Title: AN OPEN-LABEL, MULTICENTER EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF LACOSAMIDE AS ADJUNCTIVE THERAPY FOR UNCONTROLLED PRIMARY GENERALIZED TONIC-CLONIC SEIZURES IN SUBJECTS W... | ||
Medical condition: Idiopathic generalized epilepsy | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: SK (Completed) HU (Completed) DE (Completed) ES (Ongoing) CZ (Completed) PT (Completed) BE (Completed) PL (Completed) BG (Completed) FR (Completed) RO (Ongoing) Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2007-006695-10 | Sponsor Protocol Number: E2090-E044-316 | Start Date*: 2008-09-23 | |||||||||||
Sponsor Name:Eisai Limited | |||||||||||||
Full Title: Open Label Extension Study Following Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess Efficacy and Safety of Adjunctive Zonisamide in Primary Generalized Tonic-Clonic Seizures | |||||||||||||
Medical condition: Primary generalised tonic-clonic seizures (PGTCS) in idiopathic generalised epilepsy (IGE) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.